Cell and Gene Therapy Catapult at Cell 2026
Nov 12–13, 2026 London, UK ~800 attendees Website
Cell and Gene Therapy Catapult takes part in 5 sessions at Cell 2026 in London, its home city. Its program centres on viral vector manufacturing and on the path from academic research to clinical trials for advanced therapies. Specific topics include continuous vector production aimed at more affordable gene therapies, perfusion bioreactors that intensify AAV output and UK regulatory initiatives.
| Organization | Cell 2026 Attendance |
|---|---|
Cell and Gene Therapy Catapult London, UK | |
UK innovation centre helping cell and gene therapy developers with process development, GMP manufacturing space and regulatory support. | Talk Thu Nov 12 3:05pm–3:30pm Enabling Affordable Gene Therapies Through Continuous Viral Vector Manufacturing Cell and gene therapyManufacturing and CMC Talk Thu Nov 12 5:45pm–6:10pm Talk Fri Nov 13 9:25am–9:50am rAAV Production Process Intensification Using Perfusion Bioreactor Technology Cell and gene therapyCell culture and upstream processing Talk Fri Nov 13 1:55pm–2:20pm Regulatory Initiatives For ATMPs In The UK Cell and gene therapy Panel Fri Nov 13 4:40pm–5:05pm |
Instantly find 20 buyers from Cell and Gene Therapy Catapult
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Cell 2026 or its organizers. Submit a correction